News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Francisco J. Esteva: The evolution of HER2 as a pivotal biomarker in breast cancer diagnosis and treatment is a fascinating story
Photo taken from Francisco J. Esteva/LinkedIn
Jan 14, 2024, 15:07

Francisco J. Esteva: The evolution of HER2 as a pivotal biomarker in breast cancer diagnosis and treatment is a fascinating story

Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared on LinkedIn:

“The evolution of HER2 as a pivotal biomarker in breast cancer diagnosis and treatment is a fascinating story. From its discovery in the 1980s to the groundbreaking advancements in therapy, in this podcast I discuss the nuances of HER2 positive, negative, and the newly recognized HER2-Low category.

As we navigate the complexities of breast cancer, it is important to recognize how targeted therapies such as trastuzumab deruxtecan have transformed patient prognoses from the worst to some of the best outcomes in oncology.”

Proceed to video.
Source: Francisco J. Esteva/LinkedIn

Breast Cancer cancer Francisco J. Esteva groundbreaking advancements in therapy HER2 OncoDaily Oncology Target therapy
Special Coverage
Insight
Jan 20, 2025, 16:07
The AACR Hematologic Malignancies Research Fellowship
Science
Jan 20, 2025, 16:03
Amy Moore: Biomarker testing can help identify actionable mutations in patients with squamous NSCLC
Insight
Jan 20, 2025, 16:03
Navneet Singh: Ensuring global access to the 3 'A's of treatment
Blog
Jan 20, 2025, 15:56
Erman Akkus: Downstaging of HCC before liver transplantation
Blog
Jan 20, 2025, 15:45
Chris Weight: Accepting applications for the Cleveland Clinic Urology, Society of Urologic Oncology fellowship program
Blog
Jan 20, 2025, 15:41
Endoscopic Ultrasound Gastroenterostomy versus Duodenal Stenting for Malignant GOO
Science
Jan 20, 2025, 15:25
Tony Hung: A virtual integrative medicine program to improve symptoms and decrease hospitalization
Blog
Jan 20, 2025, 14:46
Gregg Margolis: Three things to read about health policy this week
Blog
Jan 20, 2025, 14:43
Afreen Shariff: Excellent to connect with fellow board members at the ACCC
Dialogues
Jan 20, 2025, 14:32
The Current Situation with Colorectal Cancer in Kazakhstan
Science
Jan 20, 2025, 14:17
Hung Trinh: Bispecific Antibodies in Cancer Therapy
Insight
Jan 20, 2025, 14:16
Amy Moore: Ensuring that all patients benefit from recent scientific advances in lung cancer